Pfizer-BioNTech's new trial to test COVID-19 vaccine booster against South African variant



Pfizer Inc and BioNTech SE are in talks with regulatory authorities about testing a vaccine modified to protect specifically against the highly transmissible new variant found in South Africa and elsewhere, known as B.1.351, as a second arm of the same study.